Acknowledgement
Supported by : NIH, Charlotte Geyer Foundation
References
- Danovi, S.A. (2009). Cancer stem cells: common as muck. Nat. Rev. Cancer 9, 6-7 https://doi.org/10.1038/nrc2563
- Ewens, A., Luo, L., Berleth, E., Alderfer, J., Wollman, R., Hafeez, B.B., Kanter, P., Mihich, E., and Ehrke, M.J. (2006). Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice. Cancer Res. 66, 5419-5426 https://doi.org/10.1158/0008-5472.CAN-05-3963
- Quintana, E., Shackleton, M., Sabel, M.S., Fullen, D.R., Johnson, T.M., and Morrison, S.J. (2008). Efficient tumour formation by single human melanoma cells. Nature 456, 593-598 https://doi.org/10.1038/nature07567
- Visvader, J.E., and Lindeman, G.J. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768 https://doi.org/10.1038/nrc2499
- Yoo, M.H., and Hatfield, D.L. (2008). The cancer stem cell theory: Is it correct? Mol. Cells 26, 514-516
- Zheng, X., Shen, G., Yang, X., and Liu, W. (2007). Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res. 67, 3691-3697 https://doi.org/10.1158/0008-5472.CAN-06-3912
Cited by
- Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types vol.29, pp.1, 2009, https://doi.org/10.1186/1756-9966-29-8
- Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability vol.18, pp.12, 2009, https://doi.org/10.1038/cgt.2011.58
- TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells vol.17, pp.8, 2009, https://doi.org/10.1007/s10495-012-0734-1